RxDoctor Payments Data

Michael Smith, PA

Physician Assistant · Massillon, OHNPI 1558557546

Payments from drug & device makers

$1,827in general payments, 2019–2025

Across 137 payments — averaging $13.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$363
  • Teva Pharmaceuticals USA, Inc.$222
  • AbbVie$196
  • Biodelivery Sciences International, Inc.$135
  • GRT US Holding, Inc.$108
  • Biohaven Pharmaceuticals, Inc.$98
  • plus $703 from 16 others

What the payments were for

  • Food & beverage$1,81499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,827 in reported general payments places this provider in the 85th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$38,473
Medicare patients
179
Services billed
571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate147$100,952
OxycontinOxycodone Hcl102$69,935
Nucynta ErTapentadol Hcl32$54,945
NucyntaTapentadol Hcl50$43,280
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,322$28,596
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,037$24,213
BelbucaBuprenorphine Hcl41$23,773
Fentanyl162$18,104
MovantikNaloxegol Oxalate44$17,695
Pregabalin636$17,381
Gabapentin1,192$17,321
Oxymorphone Hcl ErOxymorphone Hcl28$15,629
Buprenorphine47$13,737
Morphine Sulfate ErMorphine Sulfate389$10,958
Hysingla ErHydrocodone Bitartrate16$10,140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta, Belbuca$363$222,950270 claims
Scilex Pharmaceuticals Inc.Ztlido$55$8,60713 claims
AbbVieLinzess$196$8,41716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Massillon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →